| イタリア | トルコ | オーストリア | |
| 経尿道的水蒸気焼灼術 | - | から $2,200 | から $4,000 |
| 経尿道的前立腺切除術 | - | から $2,200 | から $3,500 |
| 経尿道的マイクロ波療法 | - | から $2,000 | から $3,500 |
| 前立腺摘除術 | - | から $6,340 | から $17,000 |
| 光凝固療法 | - | から $1,800 | から $6,000 |
Prof. Montorsi is one of the top Italian experts in Urology and Andrology, with numerous scientific awards and 8,000+ urology/andrology surgeries. He directs the Urological Research Institute (URI) in Italy, is recognized among the most influential researchers of the past decade, and has developed his vein patching method to correct occlusive vein dysfunction. He is an Honorary Fellow of the Royal College of Surgeons of England and has written over 1,000 papers. He is a member of various medical organizations.
Professor Fabio Carmignani is a specialist in andrology, urology, and prostatic biopsy under MRI guidance. He has been the Director of the Urology Department at Policlinico San Donato Research Hospital in Milan since 2007 and has over 10,000 surgeries to his credit. He has a medical degree from the University of Milan and is the President of the Foundation of the Italian Society of Urology. He has written over 100 research materials in urologic surgery and is a member of the American Urological Association and the Italian Society of Urology, Minimal Invasive Therapy.
Dr. Alessandro Calarco is a skilled urologist with expertise in minimally invasive and endourological procedures. He performs percutaneous lithotripsy, ureterorenoscopy, tumor ablation, and advanced reconstructive surgeries. Dr. Calarco has received international recognition for his clinical work and research. He completed advanced training in Sweden and the UK.
Dr. Calarco graduated with top honors from Università Cattolica del Sacro Cuore in Rome. He completed his Urology specialization and earned a PhD in Oncological Urology at the same university. His research focuses on prostate cancer biomarkers and exosomes. He has also helped develop clinical protocols for hormone-refractory prostate cancer.
He serves as National Head of Urology for SPIGC and is a member of the European Board of Urology. Dr. Calarco holds an international patent for a device that improves percutaneous nephrolithotripsy. He has published extensively and received several awards for surgical innovation and education.